| Structure | Chemical Name | CAS | MF |
|
suberogorgin
|
110043-85-1
|
C15H20O3
|
|
Calpain Inhibitor I
|
110044-82-1
|
C20H37N3O4
|
|
5-BROMO-2,2'-BITHIOPHENE-5'-CARBOXALDEHYDE
|
110046-60-1
|
C9H5BrOS2
|
|
Cyclobutanecarbonyl chloride, 1-methoxy- (9CI)
|
110046-66-7
|
C6H9ClO2
|
|
Rhodanine, 5-(2-naphthylmethylene)-3-phenyl-
|
110050-44-7
|
C20H13NOS2
|
|
Morpheridine dihydrochloride
|
110051-57-5
|
C20H30N2O3
|
|
2,5-Bis((3-morpholinopropyl)amino)-p-benzoquinone
|
110052-34-1
|
C20H32N4O4
|
|
9-BroMo-16α,17-epoxy-11β-hydroxyprogesterone
|
110053-24-2
|
C21H27BrO4
|
|
Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine, 5-amino-1,3,3-trimethylcyclohexanemethanamine, 1,4-butanediol, 2,2-dimethyl-1,3-propanediol, 1,2-ethanediamine, 1,6-hexanediol, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane
|
110053-40-2
|
C73H148N11NaO18
|
|
Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine, reaction products with N-(3-aminopropyl)-N-methyl-1,3-propanediamine and epichlorohydrin
|
110053-41-3
|
C20H47ClN6O5
|
|
Imidodicarbonic diamide, N,N',2-tris(6-isocyanatohexyl)-, reaction products with 3-chloro-1,2-propanediol and α-fluoro-ω-(2- hydroxyethyl)poly(difluoromethylene)
|
110053-43-5
|
|
|
|
9,12-Octadecadienoic acid (9Z,12Z)-, dimer, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, 1,3-diisocyanatomethylbenzene and 2-propenoic acid, Bu alc.-modified
|
110053-46-8
|
|
|
Urea, polymer with formaldehyde and 1,3,5-triazine-2,4,6-triamine, isobutylated
|
110053-48-0
|
C5H12N8O2
|
|
Sulfonium, (3-cyclohexyl-3-hydroxy-3-phenylpropyl)dimethyl-, iodide
|
110055-40-8
|
|
|
Acenaphtho[5,4-d]thiazole, 4,5-dihydro-8-methyl- (6CI)
|
110060-06-5
|
C14H11NS
|
|
Ethyl 6-(Benzyloxy)benzofuran-2-carboxylate
|
110060-70-3
|
C18H16O4
|
|
5-MERCAPTO-4-(2-PHENYLETHYL)-4H-1,2,4-TRIAZOL-3-OL
|
110062-45-8
|
C10H11N3OS
|
|
7-Hydroxy-3-(4-hydroxybenzylidene)chroMan-4-one
|
110064-50-1
|
C16H12O4
|
|
12-epi-Napelline
|
110064-71-6
|
C22H33NO3
|
|
2-aMino-2-phenylacetonitrile
|
110066-41-6
|
C8H8N2
|
|
|
pseudonajatoxin b
|
110068-86-5
|
|
|
|
monitor peptide
|
110070-20-7
|
|
|
|
sarcotoxin III
|
110070-77-4
|
|
|
9,9-Biphenanthrene-10,10-diol
|
110071-78-8
|
C28H18O2
|
|
TOSAGESTIN
|
110072-15-6
|
C21H24O2
|
|
2,4-bis(broMoMethyl)-1-nitrobenzene
|
110072-87-2
|
C8H7Br2NO2
|
|
5-(NEO-PENTYL)HYDANTOIN
|
110072-96-3
|
C8H14N2O2
|
|
ACETYL COENZYME A, [ACETYL-3H]
|
110073-15-9
|
C23H35N7O17P3ST3
|
|
2,4(1H,3H)-Pyrimidinedione, 1-(chloroacetyl)-5-fluoro- (9CI)
|
110073-43-3
|
C6H4ClFN2O3
|
|
2,4(1H,3H)-Pyrimidinedione, 1-(2-chloro-1-oxopropyl)-5-fluoro- (9CI)
|
110073-44-4
|
C7H6ClFN2O3
|
|
capozide
|
110075-07-5
|
C9H15NO3S.C7H8ClN3O4S2
|
|
O-CHLORAMINE T
|
110076-44-3
|
C7H7ClNNaO2S
|
|
|
hemoglobin Aztec
|
110076-72-7
|
|
|
1,1'-[1,3-PHENYLENEBIS-(METHYLENE)]-BIS-(1,4,8,11-TETRAAZACYCLOTETRADECANE) OCTAHYDROCHLORIDE
|
110078-44-9
|
C28H54N8
|
|
PLERIXAFOR
|
110078-46-1
|
C28H54N8
|
|
1,4,8,11-Tetraazacyclotetradecane, 1,1'-[1,4-phenylenebis(Methylene)]bis[4,8,11-tris[(4-Methylphenyl)sulfon yl]-
|
110078-47-2
|
C70H90N8O12S6
|
|
(2R,4R)-3-ACETYL-2-(4-CHLORO-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID
|
110078-81-4
|
C12H12ClNO3S
|
|
Spiro[2.3]hexan-4-one, 5-chloro-6,6-dimethyl-
|
110079-16-8
|
C8H11ClO
|
|
Furan, 2-(9,10-dihydro-9-anthracenyl)tetrahydro-
|
110079-20-4
|
C18H18O
|
|
N-(3-BROMOBENZYL)-N-ISOPROPYLAMINE
|
110079-41-9
|
C10H14BrN
|
|
2-(1-Hydroxypropyl) ProMazine
|
110080-35-8
|
C20H26N2OS
|
|
4(3H)-Quinazolinone, 3-ethyl-8-methoxy-2-(p-methoxystyryl)- (6CI)
|
110080-97-2
|
C20H20N2O3
|
|
ACRAMINFWR
|
110081-39-5
|
C19H44N8O2
|
|
LHRH, N-Ac-muramyl-Ala-iso-Glu-LysNH2-
|
110083-09-5
|
C80H117N23O24
|
|
H-SER-GLN-GLY-THR-PHE-THR-SER-GLU-TYR-SER-LYS-TYR-LEU-ASP-SER-ARG-ARG-ALA-GLN-ASP-PHE-VAL-GLN-TRP-LEU-MET-ASN-THR-NH2
|
110084-95-2
|
C148H221N41O47S
|
|
Acetic acid, chloronitro-, hydrazide (9CI)
|
110085-29-5
|
C2H4ClN3O3
|
|
1,2-dideoxy-3,4,5,6-di-O-isopropylidene-1,2-C-methylene-1-nitromannitol
|
110085-92-2
|
C13H21NO6
|
|
1H-Pyrazol-3-amine, 4-chloro-5-(1-methylethyl)-
|
110086-10-7
|
C6H10ClN3
|
|
5-(tert-Butyl)-4-chloro-1H-pyrazol-3-aMine
|
110086-11-8
|
C7H12ClN3
|
|
4-ACETOXY-4-METHYL-1-PENTANAL
|
110086-93-6
|
C8H14O3
|
|
Bicyclo[3.2.0]hept-6-en-2-one, 5-(1-methylethyl)- (9CI)
|
110087-09-7
|
C10H14O
|
|
Tricyclo[4.1.0.02,7]heptan-3-one, 6-(1-methylethyl)- (9CI)
|
110087-11-1
|
C10H14O
|
|
L-erythro-Penturonic acid, 4-deoxy-3-O-methyl-, gamma-lactone (9CI)
|
110089-30-0
|
C6H8O4
|
|
D-threo-Penturonic acid, 4-deoxy-3-O-methyl-, gamma-lactone (9CI)
|
110089-31-1
|
C6H8O4
|
|
1-O-hexadecyl-2-C,O-dimethylglycero-3-phosphocholine
|
110090-00-1
|
C26H56NO6P
|
|
methyl 8-(2''-hydroxyethoxy)-2',3'-O-isopropylideneadenosine-5',2''-phosphate
|
110090-92-1
|
C16H22N5O8P
|
|
1,2,4-Cyclopentanetriol,4-acetate,(1-alpha-,2-bta-,4-alpha-)-(9CI)
|
110091-49-1
|
C7H12O4
|
|
1-Butanone, 2,2-difluoro-3,3-dimethyl-1-phenyl- (9CI)
|
110097-46-6
|
C12H14F2O
|
|
|
bombyxins
|
110098-88-9
|
|
|
ASISCHEM A03574
|
110099-94-0
|
C6H6N2O2S
|
|
5-Pyrimidinecarbonyl chloride, 2-chloro- (9CI)
|
110099-99-5
|
C5H2Cl2N2O
|
|
Ethanone, 1-(2-chloro-5-pyrimidinyl)- (9CI)
|
110100-00-0
|
C6H5ClN2O
|
|
desialylated human Cad antigenic determinant
|
110101-22-9
|
C22H38N2O16
|
|
N-(Cyclohexylphenylmethyl)-4-(2-methoxyphenyl)-1-piperazinepropanamide
|
110101-64-9
|
C27H37N3O2
|
|
Tirilazadmesylate
|
110101-66-1
|
C38H52N6O2
|
|
tirilazad
|
110101-67-2
|
C39H56N6O5S
|
|
2-Methyl-2-propenoic acid, butyl ester polymer with butyl 2-propenoate, 4-(1-methylethenyl)phenol and 2-propenenitrile
|
110102-21-1
|
C27H39NO5
|
|
5-AMINO-4-CHLORO-o-CRESOL HCl
|
110102-85-7
|
C7H9Cl2NO
|
|
5-Amino-4-chloro-2-methylphenol
|
110102-86-8
|
C7H8ClNO
|
|
N2-ACETYL-9-[(2'-HYDROXYETHOXY)METHYL]GUANINE
|
110104-37-5
|
C10H13N5O4
|
|
METHYL (E)-4-CHLORO-3-METHOXY-2-BUTENOATE
|
110104-60-4
|
C6H9ClO3
|
|
PIPERIDINE-4-CARBOXYLIC ACID PYRIDIN-2-YLAMIDE
|
110105-31-2
|
C11H15N3O
|
|
PIPERIDINE-4-CARBOXYLIC ACID PYRIDIN-4-YLAMIDE
|
110105-35-6
|
C11H15N3O
|
|
PIPERIDINE-3-CARBOXYLIC ACID PYRIDIN-4-YLAMIDE
|
110105-42-5
|
C11H15N3O
|
|
PIPERIDINE-4-CARBOXYLIC ACID (5-METHYL-PYRIDIN-2-YL)-AMIDE
|
110105-97-0
|
C12H17N3O
|
|
PIPERIDINE-4-CARBOXYLIC ACID (6-METHYL-PYRIDIN-2-YL)-AMIDE
|
110105-99-2
|
C12H17N3O
|
|
2-O-BETA-L-ARABINOPYRANOSYL MYO-INOSITOL
|
110107-23-8
|
C11H20O10
|
|
ETHYL 3-(3-FORMYLPHENYL)PROPANOATE
|
110114-05-1
|
C12H14O3
|
|
CALPAIN INHIBITOR II
|
110115-07-6
|
C19H35N3O4S
|
|
2,3-Oxiranedicarboxylicacid,monomethylester,(2S-cis)-(9CI)
|
110115-15-6
|
C5H6O5
|
|
2,3-Oxiranedicarboxylicacid,monomethylester,(2R-cis)-(9CI)
|
110115-16-7
|
C5H6O5
|
|
(R)-2,5-Dihydro-3,6-diethoxy-2-isopropylpyrazine
|
110117-71-0
|
C11H20N2O2
|
|
1-METHYL-D-TRYPTOPHAN
|
110117-83-4
|
C12H14N2O2
|
|
3-FLUORO-D-PHENYLALANINE
|
110117-84-5
|
C9H10FNO2
|
|
allatostatin
|
110119-33-0
|
C61H94N18O16
|
|
|
antistasin
|
110119-38-5
|
|
|
DONEPEZIL HYDROCHLORIDE
|
110119-84-1
|
C24H30ClNO3
|
|
|
hemoce
|
110120-01-9
|
|
|
1,2-(oleoyl)-N-(6-((7-nitrobenz-2-oxa-1,3-diazo-4-yl)aminocaproyl))phosphatidylinositol
|
110121-15-8
|
C39H65N4O16P
|
|
3-Isoquinolinecarboxylicacid,7-amino-6-hydroxy-(9CI)
|
110121-33-0
|
C10H8N2O3
|
|
POLY(4-VINYLPHENOL-CO-2-HYDROXYETHYL METHACRYLATE)
|
110123-09-6
|
C14H18O4
|
|
lexitropsin
|
110124-49-7
|
C20H29N5O4
|
|
4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone
|
110124-55-5
|
C11H12N2O2
|
|
1 4-BIS(2-ETHYLHEXYLOXY)BENZENE 97
|
110126-93-7
|
C22H38O2
|
|
2,6-DIBROMO-4-NITROTOLUENE
|
110127-07-6
|
C7H5Br2NO2
|
|
2H-Pyran,6-ethoxytetrahydro-3-methyl-2-(2-propenyloxy)-(9CI)
|
110128-72-8
|
C11H20O3
|
|
2H-Pyran,6-ethoxytetrahydro-3-methyl-2-(1-propenyloxy)-(9CI)
|
110128-74-0
|
C11H20O3
|
|
2H-Pyran-2-ethanol,6-ethoxytetrahydro-bta,3-dimethyl-(9CI)
|
110128-76-2
|
C11H22O3
|
|
(Z)-2-(2-AMINOTHIAZOL-4-YL)-2-ACETYLOXYIMINOACETIC ACID
|
110130-88-6
|
C7H7N3O4S
|
|
4H-1-Benzopyran-4-one, 5,8-dichloro-
|
110138-35-7
|
C9H4Cl2O2
|